Skip to content

13F-HR filed by SR One Capital Management, LP

SR One Capital Management, LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 13 holding rows worth $461,375,729.

Accession
0000950123-25-008422
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 13 entries on the cover page, a total value of $461,375,729 stated on the cover page (in dollars after the unit check, H1), rows summing to $461,375,729 with VALUE read as dollars as filed, 13F file number 028-21964. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARCELLX INC COMMON STOCK03940C100Stock2,346,630$154,525,586dollars as filed
ARS PHARMACEUTICALS INC82835W108COM4,012,903$70,025,157dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,048,951$51,020,977dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock4,911,539$47,592,813dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,514,929$45,826,529dollars as filed
MINERALYS THERAPEUTICS INC603170101COM3,127,933$42,320,934dollars as filed
DESIGN THERAPEUTICS INC25056L103COM6,526,476$21,994,224dollars as filed
OCULIS HOLDING AGH5870P102CMN322,500$6,259,725dollars as filed
ALUMIS INC022307102COM1,959,896$5,879,688dollars as filed
NKARTA INC65487U108COMMON STOCK3,333,333$5,533,333dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock430,330$4,823,999dollars as filed
KALA BIO INC483119202COM NEW598,940$2,850,954dollars as filed
ENGENE HOLDINGS INC29286M105COM747,750$2,721,810dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-008422this filing2025-08-14acceptance time not in the bulk data set